{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:17:26Z","timestamp":1791191846080,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,11,10]],"date-time":"2009-11-10T00:00:00Z","timestamp":1257811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00702-009-0334-6","type":"journal-article","created":{"date-parts":[[2009,11,9]],"date-time":"2009-11-09T07:46:40Z","timestamp":1257752800000},"page":"97-104","source":"Crossref","is-referenced-by-count":63,"title":["Association between the RAGE G82S polymorphism and Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"117","author":[{"given":"Keshen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songpo","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,10]]},"reference":[{"key":"334_CR1","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1038\/sj.emboj.7600415","volume":"23","author":"O Arancio","year":"2004","unstructured":"Arancio O, Zhang HP, Chen X, Lin C, Trinchese F, Puzzo D, Liu S, Hegde A, Yan SF, Stern A, Luddy JS, Lue LF, Walker DG, Roher A, Buttini M, Mucke L, Li W, Schmidt AM, Kindy M, Hyslop PA, Stern DM, Du Yan SS (2004) RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice. EMBO J 23:4096\u20134105","journal-title":"EMBO J"},{"key":"334_CR2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2174\/1389450043345308","volume":"5","author":"M Cacquevel","year":"2004","unstructured":"Cacquevel M, Lebeurrier N, Ch\u00e9enne S, Vivien D (2004) Cytokines in neuroinflammation and Alzheimer\u2019s disease. Curr Drug Targets 5:529\u2013534","journal-title":"Curr Drug Targets"},{"key":"334_CR3","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.clinbiochem.2008.05.007","volume":"41","author":"M Catalano","year":"2008","unstructured":"Catalano M, Cortelazzo A, Santi R, Contino L, Demicheli M, Yilmaz Y, Zorzetto M, Campo I, Lanati N, Emanuele E (2008) The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (receptor for advanced glycation endproducts) and the presence of peripheral arterial disease. Clin Biochem 41:981\u2013985","journal-title":"Clin Biochem"},{"key":"334_CR4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbadis.2005.03.014","volume":"1741","author":"MO Chaney","year":"2005","unstructured":"Chaney MO, Stine WB, Kokjohn TA, Kuo YM, Esh C, Rahman A, Luehrs DC, Schmidt AM, Stern D, Yan SD, Roher AE (2005) RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling. Biochim Biophys Acta 1741:199\u2013205","journal-title":"Biochim Biophys Acta"},{"key":"334_CR5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2174\/156652407783220741","volume":"7","author":"X Chen","year":"2007","unstructured":"Chen X, Walker DG, Schmidt AM, Arancio O, Lue LF, Yan SD (2007) RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer\u2019s disease. Curr Mol Med 7:735\u2013742","journal-title":"Curr Mol Med"},{"key":"334_CR6","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1073\/pnas.0336073100","volume":"100","author":"A Convit","year":"2003","unstructured":"Convit A, Wolf OT, Tarshish C, de Leon MJ (2003) Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci USA 100:2019\u20132022","journal-title":"Proc Natl Acad Sci USA"},{"key":"334_CR7","first-page":"449","volume":"58","author":"RS Doody","year":"2001","unstructured":"Doody RS, Massman P, Dunn JK (2001) A method for estimating progression rates in Alzheimer disease. Arch Neurol 58:449\u2013454","journal-title":"Arch Neurol"},{"key":"334_CR8","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1001\/archneur.62.11.1734","volume":"62","author":"E Emanuele","year":"2005","unstructured":"Emanuele E, D\u2019Angelo A, Tomaino C, Binetti G, Ghidoni R, Politi P, Bernardi L, Maletta R, Bruni AC, Geroldi D (2005) Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Arch Neurol 62:1734\u20131736","journal-title":"Arch Neurol"},{"key":"334_CR9","doi-asserted-by":"crossref","unstructured":"Ertekin-Taner N (2007) Genetics of Alzheimer\u2019s disease: a centennial review. Neurol Clin 25:611\u2013667, v","DOI":"10.1016\/j.ncl.2007.03.009"},{"key":"334_CR10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00702-008-0069-9","volume":"115","author":"R Ghidoni","year":"2008","unstructured":"Ghidoni R, Benussi L, Glionna M, Franzoni M, Geroldi D, Emanuele E, Binetti G (2008) Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment. J Neural Transm 115:1047\u20131050","journal-title":"J Neural Transm"},{"key":"334_CR11","first-page":"A291","volume":"634","author":"RCP Go","year":"1998","unstructured":"Go RCP, Collins JS, Watson B Jr, Vanichanan CJ, Acton RT, Blacker D, Albert MS, Tanzi R, McInnis MG, Bassett SS, Campbell D, Perry RT (1998) Evidence for linkage to 6p21.3 in Alzheimer disease families containing APOE E4\/E4 genotypes. Am J Hum Genet 634:A291","journal-title":"Am J Hum Genet"},{"key":"334_CR12","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1158\/1078-0432.CCR-07-4808","volume":"14","author":"H Gu","year":"2008","unstructured":"Gu H, Yang L, Sun Q, Zhou B, Tang N, Cong R, Zeng Y, Wang B (2008) Gly82Ser polymorphism of the receptor for advanced glycation end products is associated with an increased risk of gastric cancer in a Chinese population. Clin Cancer Res 14:3627\u20133632","journal-title":"Clin Cancer Res"},{"key":"334_CR13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","volume":"18","author":"L Ho","year":"2004","unstructured":"Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, Peng Y, Cambareri G, Rocher A, Mobbs CV, Hof PR, Pasinetti GM (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease. FASEB J 18:902\u2013904","journal-title":"FASEB J"},{"key":"334_CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.gene.6363861","volume":"3","author":"MA Hofmann","year":"2002","unstructured":"Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y, Lalla E, Chitnis S, Monteiro J, Stickland MH, Bucciarelli LG, Moser B, Moxley G, Itescu S, Grant PJ, Gregersen PK, Stern DM, Schmidt AM (2002) RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun 3:123\u2013135","journal-title":"Genes Immun"},{"key":"334_CR15","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2337\/diabetes.47.7.1155","volume":"47","author":"BI Hudson","year":"1998","unstructured":"Hudson BI, Stickland MH, Grant PJ (1998) Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes 47:1155\u20131157","journal-title":"Diabetes"},{"key":"334_CR16","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2337\/diabetes.50.6.1505","volume":"50","author":"BI Hudson","year":"2001","unstructured":"Hudson BI, Stickland MH, Futers TS, Grant P (2001) Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50:1505\u20131511","journal-title":"Diabetes"},{"key":"334_CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.metabol.2006.09.013","volume":"56","author":"Y Jang","year":"2007","unstructured":"Jang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, Koh SJ, Lee HC, Ahn CW, Song YD, Lee JH (2007) Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism 56:199\u2013205","journal-title":"Metabolism"},{"key":"334_CR18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","volume":"11","author":"FM LaFerla","year":"2005","unstructured":"LaFerla FM, Oddo S (2005) Alzheimer\u2019s disease: Abeta, tau and synaptic dysfunction. Trends Mol Med 11:170\u2013176","journal-title":"Trends Mol Med"},{"key":"334_CR19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jnnp.2003.017368","volume":"75","author":"JC Lambert","year":"2004","unstructured":"Lambert JC, Mann D, Harris J, Araria-Goumidi L, Chartier-Harlin MC, Cottel D, Iwatsubo T, Amouyel P, Lendon C (2004) Association study of Notch 4 polymorphisms with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 75:377\u2013381","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"334_CR20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2001.7732","volume":"171","author":"LF Lue","year":"2001","unstructured":"Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, Stern DM, Yan SD (2001) Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer\u2019s disease: identification of a cellular activation mechanism. Exp Neurol 171:29\u201345","journal-title":"Exp Neurol"},{"key":"334_CR21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1568007054038210","volume":"4","author":"LF Lue","year":"2005","unstructured":"Lue LF, Yan SD, Stern DM, Walker DG (2005) Preventing activation of receptor for advanced glycation endproducts in Alzheimer\u2019s disease. Curr Drug Targets CNS Neurol Disord 4:249\u2013266","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"334_CR22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000164275","volume":"26","author":"SL Ma","year":"2008","unstructured":"Ma SL, Tang NL, Tam CW, Lui VW, Suen EW, Chiu HF, Lam LC (2008) Association between HLA-A alleles and Alzheimer\u2019s disease in a southern Chinese community. Dement Geriatr Cogn Disord 26:391\u2013397","journal-title":"Dement Geriatr Cogn Disord"},{"key":"334_CR23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/147323000703500407","volume":"35","author":"T Matsui","year":"2007","unstructured":"Matsui T, Yamagishi S, Ueda S, Nakamura K, Imaizumi T, Takeuchi M, Inoue H (2007) Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation. J Int Med Res 35:482\u2013489","journal-title":"J Int Med Res"},{"key":"334_CR24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease. Neurology 34:939\u2013944","journal-title":"Neurology"},{"key":"334_CR25","doi-asserted-by":"crossref","first-page":"14998","DOI":"10.1016\/S0021-9258(18)42138-2","volume":"267","author":"M Neeper","year":"1992","unstructured":"Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998\u201315004","journal-title":"J Biol Chem"},{"key":"334_CR26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1679\/aohc.70.279","volume":"70","author":"I Nozaki","year":"2007","unstructured":"Nozaki I, Watanabe T, Kawaguchi M, Akatsu H, Tsuneyama K, Yamamoto Y, Ohe K, Yonekura H, Yamada M, Yamamoto H (2007) Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer\u2019s disease brains. Arch Histol Cytol 70:279\u2013290","journal-title":"Arch Histol Cytol"},{"key":"334_CR27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.mcn.2005.02.012","volume":"29","author":"IG Onyango","year":"2005","unstructured":"Onyango IG, Tuttle JB, Bennett JP Jr (2005) Altered intracellular signaling and reduced viability of Alzheimer\u2019s disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE). Mol Cell Neurosci 29:333\u2013343","journal-title":"Mol Cell Neurosci"},{"key":"334_CR28","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1523\/JNEUROSCI.0204-08.2008","volume":"28","author":"N Origlia","year":"2008","unstructured":"Origlia N, Righi M, Capsoni S, Cattaneo A, Fang F, Stern DM, Chen JX, Schmidt AM, Arancio O, Yan SD, Domenici L (2008) Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction. J Neurosci 28:3521\u20133530","journal-title":"J Neurosci"},{"key":"334_CR29","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.molimm.2003.11.027","volume":"40","author":"IH Park","year":"2004","unstructured":"Park IH, Yeon SI, Youn JH, Choi JE, Sasaki N, Choi IH, Shin JS (2004) Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells. Mol Immunol 40:1203\u20131211","journal-title":"Mol Immunol"},{"key":"334_CR30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2370.1999.00168.x","volume":"26","author":"G Prevost","year":"1999","unstructured":"Prevost G, Fajardy I, Fontaine P, Danze PM, Besmond C (1999) Human RAGE GLY82SER dimorphism and HLA class II DRB1-DQA1-DQB1 haplotypes in type 1 diabetes. Eur J Immunogenet 26:343\u2013348","journal-title":"Eur J Immunogenet"},{"key":"334_CR31","doi-asserted-by":"crossref","first-page":"R817","DOI":"10.1186\/ar1749","volume":"7","author":"R Pullerits","year":"2005","unstructured":"Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A (2005) Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 7:R817\u2013R824","journal-title":"Arthritis Res Ther"},{"key":"334_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbaexp.2003.08.008","volume":"1630","author":"C Schlueter","year":"2003","unstructured":"Schlueter C, Hauke S, Flohr AM, Rogalla P, Bullerdiek J (2003) Tissue-specific expression patterns of the RAGE receptor and its soluble forms\u2014a result of regulated alternative splicing? Biochim Biophys Acta 1630:1\u20136","journal-title":"Biochim Biophys Acta"},{"key":"334_CR33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-4889(00)00087-2","volume":"1498","author":"AM Schmidt","year":"2000","unstructured":"Schmidt AM, Yan SD, Yan SF, Stern DM (2000) The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 1498:99\u2013111","journal-title":"Biochim Biophys Acta"},{"key":"334_CR34","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI200114002","volume":"108","author":"AM Schmidt","year":"2001","unstructured":"Schmidt AM, Yan SD, Yan SF, Stern DM (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108:949\u2013955","journal-title":"J Clin Invest"},{"key":"334_CR35","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/hipo.20470","volume":"18","author":"AM Stranahan","year":"2008","unstructured":"Stranahan AM, Norman ED, Lee K, Cutler RG, Telljohann RS, Egan JM, Mattson MP (2008) Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 18:1085\u20131088","journal-title":"Hippocampus"},{"key":"334_CR36","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1523\/JNEUROSCI.4878-07.2008","volume":"28","author":"E Sturchler","year":"2008","unstructured":"Sturchler E, Galichet A, Weibel M, Leclerc E, Heizmann CW (2008) Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity. J Neurosci 28:5149\u20135158","journal-title":"J Neurosci"},{"key":"334_CR37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1006\/geno.1994.1517","volume":"23","author":"K Sugaya","year":"1994","unstructured":"Sugaya K, Fukagawa T, Matsumoto K, Mita K, Takahashi E, Ando A, Inoko H, Ikemura T (1994) Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics 23:408\u2013419","journal-title":"Genomics"},{"key":"334_CR38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1567205043480582","volume":"1","author":"M Takeuchi","year":"2004","unstructured":"Takeuchi M, Kikuchi S, Sasaki N, Suzuki T, Watai T, Iwaki M, Bucala R, Yamagishi S (2004) Involvement of advanced glycation end-products (AGEs) in Alzheimer\u2019s disease. Curr Alzheimer Res 1:39\u201346","journal-title":"Curr Alzheimer Res"},{"key":"334_CR39","doi-asserted-by":"crossref","first-page":"25781","DOI":"10.1074\/jbc.M001235200","volume":"275","author":"N Tanaka","year":"2000","unstructured":"Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H (2000) The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 275:25781\u201325790","journal-title":"J Biol Chem"},{"key":"334_CR40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2005.08.017","volume":"245","author":"GS Watson","year":"2006","unstructured":"Watson GS, Craft S (2006) Insulin resistance, inflammation, and cognition in Alzheimer\u2019s disease: lessons for multiple sclerosis. J Neurol Sci 245:21\u201333","journal-title":"J Neurol Sci"},{"key":"334_CR41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","volume":"382","author":"SD Yan","year":"1996","unstructured":"Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease. Nature 382:685\u2013691","journal-title":"Nature"},{"key":"334_CR42","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1073\/pnas.94.10.5296","volume":"94","author":"SD Yan","year":"1997","unstructured":"Yan SD, Zhu H, Fu J, Yan SF, Roher A, Tourtellotte WW, Rajavashisth T, Chen X, Godman GC, Stern D, Schmidt AM (1997) Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci USA 94:5296\u20135301","journal-title":"Proc Natl Acad Sci USA"},{"key":"334_CR43","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1007\/s00125-006-0437-7","volume":"49","author":"T Yoshida","year":"2006","unstructured":"Yoshida T, Yamagishi S, Nakamura K, Matsui T, Imaizumi T, Takeuchi M, Koga H, Ueno T, Sata M (2006) Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation. Diabetologia 49:3094\u20133099","journal-title":"Diabetologia"},{"key":"334_CR44","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.metabol.2004.11.001","volume":"54","author":"K Yoshioka","year":"2005","unstructured":"Yoshioka K, Yoshida T, Takakura Y, Umekawa T, Kogure A, Toda H, Yoshikawa T (2005) Association study of G1704T and G82S polymorphisms of RAGE gene for microalbuminuria in Japanese type 2 diabetic patients. Metabolism 54:488\u2013491","journal-title":"Metabolism"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-009-0334-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-009-0334-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-009-0334-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T17:59:56Z","timestamp":1634147996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-009-0334-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,10]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["334"],"URL":"https:\/\/doi.org\/10.1007\/s00702-009-0334-6","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,10]]}}}